Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
- Status
- TERMINATED
- Phase
- PHASE2
Early Integration of Palliative and Supportive Care in Cellular Therapy
- Status
- RECRUITING
- Phase
- NA
Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib
- Status
- UNKNOWN
- Phase
- NA
A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE4
FT576 in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.
- Status
- COMPLETED
- Phase
- N/A
Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment
- Status
- UNKNOWN
- Phase
- PHASE2
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- Status
- RECRUITING
- Phase
- PHASE1
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
- Status
- RECRUITING
- Phase
- NA
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
- Status
- COMPLETED
- Phase
- NA